Skip to content

4 November 2021

Move over Appen: A new artificial intelligence stock to list on the ASX

Medical-heart

After closing our initial public offering (IPO), the Motley Fool shares details on Artrya's AI technology and how it could disrupt the detection of coronary artery disease for years to come. Read it here.